Auxano Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79M Sell
15,490
-785
-5% -$183K 0.76% 19
2025
Q4
$3.37M Buy
16,275
+109
+0.7% +$21.6K 0.67% 22
2025
Q3
$3M Buy
16,166
+531
+3% +$91K 0.64% 24
2025
Q2
$2.39M Buy
15,635
+630
+4% +$96.8K 0.56% 28
2025
Q1
$2.49M Sell
15,005
-843
-5% -$132K 0.66% 25
2024
Q4
$2.29M Buy
15,848
+1,408
+10% +$218K 0.58% 28
2024
Q3
$2.34M Sell
14,440
-44
-0.3% -$7.01K 0.61% 28
2024
Q2
$2.12M Buy
14,484
+1,657
+13% +$246K 0.59% 29
2024
Q1
$2.03M Buy
12,827
+810
+7% +$129K 0.59% 32
2023
Q4
$1.88M Sell
12,017
-305
-2% -$46.8K 0.63% 27
2023
Q3
$1.92M Sell
12,322
-5,402
-30% -$891K 0.78% 25
2023
Q2
$2.75M Hold
17,724
1.1% 23
2023
Q1
$2.75M Buy
17,724
+2,518
+17% +$407K 1.1% 23
2022
Q4
$2.69M Buy
15,206
+69
+0.5% +$11.9K 1.21% 22
2022
Q3
$2.47M Buy
15,137
+1,412
+10% +$239K 1.14% 22
2022
Q2
$2.44M Buy
13,725
+403
+3% +$71.8K 1.21% 22
2022
Q1
$2.36M Sell
13,322
-51
-0.4% -$8.68K 1.01% 21
2021
Q4
$2.29M Buy
13,373
+151
+1% +$24.7K 1.02% 21
2021
Q3
$2.13M Hold
13,222
0.96% 20
2021
Q2
$2.18M Buy
13,222
+65
+0.5% +$10.8K 1% 19
2021
Q1
$2.16M Buy
13,157
+159
+1% +$25.7K 1.33% 20
2020
Q4
$2.05M Buy
12,998
+784
+6% +$116K 1.35% 17
2020
Q3
$1.82M Sell
12,214
-43
-0.4% -$6.36K 1.41% 18
2020
Q2
$1.72M Buy
12,257
+201
+2% +$29.3K 1.43% 18
2020
Q1
$1.58M Buy
+12,056
New +$1.71M 1.44% 17

Other funds holding JNJ

Auxano Advisors's JNJ Position: Q1 2026 in Review

Auxano Advisors reduced its Johnson & Johnson (JNJ) stake by 4.8% in Q1 2026, selling an estimated $183K and leaving 15,490 shares worth $3.79M. The position accounts for 0.76% of the portfolio, ranked #19.

Auxano Advisors first reported a position in JNJ in Q1 2020 and has held it in 25 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Auxano Advisors held 15,490 shares of Johnson & Johnson worth $3.79M as of Q1 2026.
  • Auxano Advisors sold 785 Johnson & Johnson shares in Q1 2026, an estimated $183K.
  • Johnson & Johnson made up 0.76% of Auxano Advisors's portfolio in Q1 2026, its #19 holding.
  • Auxano Advisors first reported a position in Johnson & Johnson in Q1 2020 and has held it in 25 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Auxano Advisors's 13F filing for Q1 2026, filed 4 May 2026.